Finance

Beta
Lists
19X:FRA
Axsome Therapeutics Inc
€189.20
-3.15%
(-6.15) 1D
Jun 3, 8:07:31 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 19X...
Open
€189.20
High
€189.20
Low
€189.20
Mkt. cap
11.43B
Avg. vol.
39.00
Volume
0.00
52-wk high
€204.60
52-wk low
€85.70
No. of employees
1K
Open
€189.20
High
€189.20
Low
€189.20
Mkt. cap
11.43B
Avg. vol.
39.00
Volume
0.00
52-wk high
€204.60
52-wk low
€85.70
No. of employees
1K
News stories
From sources across the web
About Axsome Therapeutics Inc
CEOHerriot Tabuteau
Employees1.22K
Founded2012
Headquarters-
SectorPharmaceutical industry
Websiteaxsome.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
150.04M
170.99M
196.00M
191.20M
Cost of goods sold
13.45M
11.91M
12.33M
14.72M
Cost of revenue
13.45M
11.91M
12.33M
14.72M
Research and development expenses
49.54M
40.16M
48.79M
52.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
130.28M
150.24M
169.30M
185.00M
Operating expense
181.41M
192.00M
219.70M
239.24M
Total operating expenses
194.86M
203.92M
232.02M
253.97M
Operating income
-44.82M
-32.92M
-36.02M
-62.77M
Other non operating income
-
-
-
-
EBT including unusual items
-48.93M
-47.23M
-28.13M
-64.54M
EBT excluding unusual items
-46.65M
-34.04M
-37.20M
-63.95M
Income tax expense
-960.00K
-
430.00K
-
Effective tax rate
1.96%
-
-1.53%
-
Other operating expenses
-
-
-
-
Net income
-47.97M
-47.23M
-28.56M
-64.54M
Net profit margin
-31.97%
-27.62%
-14.57%
-33.76%
Earnings per share
-0.97
-0.94
-0.56
-1.26
Interest and investment income
2.25M
2.26M
2.04M
1.91M
Interest expense
-4.09M
-3.38M
-3.21M
-3.09M
Net interest expenses
-1.83M
-1.12M
-1.17M
-1.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
-43.11M
-31.20M
-32.12M
-60.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer